Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

WMDA StandardTitle and link to documentExplanationStatus

3.22

3.22.2


Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee.

Bone Marrow Transplantation 49:880-886

Guidance for assessing the medical suitability for adult volunteer donors

The paper provides a background to unrelated adult donor and recipient safety, recommends a common framework for assessing the health of unrelated adult donors at each stage of the donation pathway and presents a novel mechanism for sharing international consensus criteria for individual medical and lifestyle conditions.


The guidance below reflects the consensus opinion provided by the WMDA donor medical suitability committee. The purpose of this guidance is to provide globally harmonised medical assessment criteria which simultaneously protect the interest of donors whilst ensuring the safety of cellular products across international boundaries.

Current (2017)


3.02

Qualifications and training of adult stem cell donor recruiters: recommendations by the World Marrow Donor Association

Bone Marrow Transplantation (2013) 48: 1480150

Paper providing recommendations regarding qualifications and training of recruiters

Key Performance Indicators for Registries

3.03, 3.04, 3.09, 6.07, 6.07.1, 3.24, 10.11, 10.13

Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations.

Bone Marrow Transplantation (2010) 45: 832-838

This paper is providing information about the donor care standards of the WMDA. The paper has been published in 2010, the wording of the WMDA Standards might have changed over time.Current (2017)




...

WMDA StandardTitle and link to documentExplanationStatus

2.11.2

World marrow donor association crisis response, business continuity, and disaster recovery guidelines.

Biology of Blood and Marrow Transplantation (2012) 18: 1785-1789

This paper cover the minimal requirements of preparedness in prevention and mitigation, crisis response, business continuity, and disaster recovery, and the need for continued maintenance and revision. Issues of international cooperation are addressed as well.Current (2017)
























Finance and administration

...

WMDA StandardTitle and link to documentExplanationStatus

9.02

Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT).

Global consensus document to perform long-term follow up on donors till 10 years after donation.Current (2017)

Suitability Criteria for Adult Related Donors: A Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues.



Archived Publications

WMDA StandardTitle and link to documentExplanationStatus

3.04, 3.05, 3.06, 3.09, 3.10.1, 3.11, 3.11.1, 3.13, 3.15

Informed consent--suggested procedures for informed consent for unrelated haematopoietic stem cell donors at various stages of recruitment, donor evaluation, and donor workup.

Bone Marrow Transplantation (2003) 31: 539-545

This is a checklist to set up an informed consent at the various stages. The paper has been replaced by the WMDA Guidance to explain the WMDA Standards. The guidance can be found at: https://share.wmda.info/x/0wB7CwOut of date


Standards, regulations  and accreditation for registries involved in the worldwide exchange of hematopoietic stem cell donors and products.

Bone Marrow Transplantation (2010), 45:819-824

WMDA has developed online documentation to explain the accreditation process, which is available at WMDA Share under the pillar: 'Ensuring Quality'Out of date

International exchange of cord blood units; the registry aspects

Bone Marrow Transplantation (2010), 45: 825-831

Replaced by chapter 6 of the WMDA handbook: a gift of lifeOut of date
8.05

Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilisation of stem cells in normal donors: position of World Marrow Donor Association.

Haematologica (2011): 96:942-943

The aim of this paper is to review the basis of regulatory approval of the biosimilar G-CSF agents, including the available safety data, with reference to the indication for mobilization of PBSC in normal donors and to make recommendations based on these.

The recommendation has been updated in 2017.

Out of date
3.22

Haematopoietic stem cell donor registries: World Marrow Donor Association recommendations for evaluation of donor health.

Bone Marrow Transplantation (2008) 42: 9-14


This document describes criteria for permanent or temporary deferral, guidelines for risk evaluation of infectious disease, examples of conditions requiring assessment and questionnaires designed to elicit relevant information about a donor's medical history and general health.

The paper has been updated in 2014.

Out of date





















Page Tree
root@home
excerpttrue